Press release
Market Size of Chemotherapy Induced Myelosuppression Treatment, Forecast Report 2016-2026
Chemotherapy Induced Myelosuppression Treatment Market: Drivers and Restraints
The major factor driving the growth of chemotherapy induced myelosuppression market is increasing incidence of cancer. According to World Health Organization, approximately 8.2 Mn deaths were reported due to cancer in the year 2012. Also, it is predicted that annual cancer cases will rise from 14 Mn to 22 Mn in next two decades. In addition, it is stated by National Cancer Institute that there were approximately 1,660,290 cases reported in the U.S. in 2013. Increasing incidences of cancer increases the risk of myelosuppression and hence is anticipated to drive market growth during the forecast period. However, less number of commercially available drugs for the treatment of myelosuppression may restrain the market growth.
Chemotherapy Induced Myelosuppression Treatment Market: Segmentation
The global chemotherapy induced myelosuppression treatment market has been classified on the basis of product type, end use and geography.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1364
Based on product type, the global chemotherapy induced myelosuppression treatment market is divided into following:
Granulocyte Colony-Stimulating Factor (G-CSF)
Recombinant human erythropoietin erythropoiesis-stimulating agents (ESAs)
Granulocyte-macrophage colony-stimulating factor (GM-CSF)
Antibiotics
Thrombopoietic Agents
Peripheral Blood Stem Cells
Based on end user type, the global chemotherapy induced myelosuppression treatment marketis divided into following:
Hospitals
Clinics
Cancer rehabilitation centers
Chemotherapy Induced Myelosuppression Treatment Market: Overview
Due to the availability of variety of chemotherapeutic agents for cancer treatment, the risk of myelosuppression is expected to increase significantly. Thus, pharmaceutical and biopharmaceutical industries are focusing on the research and development of myelosuppression treatment. The Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte-macrophage colony-stimulating factor (GM-CSF) segments are projected to collectively hold a major share owing to the patient’s effective response by these therapies. The first line of treatment for chemotherapy induced myelosuppression is reducing the dose of chemotherapeutic agents though the chemotherapy is continued for the treatment of cancer.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1364
Chemotherapy Induced Myelosuppression Treatment Market: Regional Overview
Geographically, the global chemotherapy induced myelosuppression treatment market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. U.S. is the largest chemotherapy induced myelosuppression market while Europe is considered as the second largest market for chemotherapy induced myelosuppression. Large patient base with increasing geriatric population in these regions drives the growth of this market. The market of chemotherapy induced myelosuppression in APAC is expected to grow at a rapid pace owing to a rise in total number of newly diagnosed patient population in this region. According to World Health Organization, 60% of the world’s total annual cases of cancer occur in Africa, Asia and Latin America which is aniticipated to boost market growth in the regions.
Chemotherapy Induced Myelosuppression Treatment Market: Key Players
Some of the key players in chemotherapy induced myelosuppression market are Novartis Pharmaceuticals, Merc & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc., Celgen Corporation, Amgen Inc., Teva pharmaceutical Industries Ltd., Biocon, Emcure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., and Abbott.
Browse Full Report@ http://www.futuremarketinsights.com/reports/chemotherapy-induced-myelosuppression-treatment-market
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Market Size of Chemotherapy Induced Myelosuppression Treatment, Forecast Report 2016-2026 here
News-ID: 352163 • Views: …
More Releases from Future Market Insights
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,…
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry…
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033.
The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable…
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute…
More Releases for Myelosuppression
Chemotherapy-Induced Myelosuppression Treatment Market advanced Research & Growt …
A new study by FMI reveals that the chemotherapy-induced myelosuppression treatment market is expected to grow at a subdued 3% y-o-y in 2019. Valued at nearly US$ 7 billion in 2018, gains are likely to be driven by a combination of multipronged factors, including,
• Development of natural product interventions for chemotherapy-induced side effects
• Growing implementation of radiation treatment in cancer treatment owing to the associated high success rate of chemotherapy
• Growing R&D investments…
Chemotherapy-Induced Myelosuppression Treatment Market | What is Negative Impact …
Chemotherapy-Induced Myelosuppression Treatment Market report will provide one with overall market analysis, statistics, various trends, drivers, opportunities, restraints, and every minute data relating to the Synthetic Fibers market necessary for forecasting its revenue, factors propelling & growth. The Chemotherapy-Induced Myelosuppression Treatment market study provides unique guidance in thoughtful details regarding the development factors and has used a top-down and bottom-up approach to keep it error-free and accurate. Our expert analysts…
Chemotherapy-Induced Myelosuppression Treatment Market with Rising Demand and Ch …
Allied Market Research published a report, titled, “Chemotherapy-Induced Myelosuppression Treatment Market: Global Opportunity Analysis and Industry Forecast, 2020-2027". According to the report, the Global Chemotherapy-Induced Myelosuppression Treatment industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027.
Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/11290
Major players analyzed include Novartis AG, Amgen Inc., Pfizer Inc., Mylan NV, Teva…
Global Chemotherapy-Induced Myelosuppression Treatment Market Expanding Massivel …
The "Chemotherapy-Induced Myelosuppression Treatment Market: by Indication (Anaemia, Neutropenia and Thrombocytopenia); by Drug Class (Thrombopoietic Agents, Erythropoietin Stimulating Agents, Iron Supplements, Growth Factors and Others); by Route of Administration (Injectable and Oral); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025" report has been added to Zion Market Research 's offering. The Chemotherapy-Induced Myelosuppression Treatment Market research report is…
Radiation-Induced Myelosuppression Treatment Market : Retail & Industry Trends & …
Rapidly improving healthcare infrastructure and reimbursement scenario has been a major booster for the healthcare industry in developing regional markets. With incessantly increasing number of cancer cases, it is more likely that the subsequent demand for a wide range of treatments adopted to treat cancer patients would also remain on a constant rise over the course of coming years. Radiation therapy has been a significant part of cancer treatment…
Chemotherapy-Induced Myelosuppression Treatment Market: 2025- Estimates and Fore …
The analysis presents a comprehensive evaluation of this global Chemotherapy-Induced Myelosuppression Treatment market allowing technologies, key trends and market drivers, challenges, and standardization, regulatory arena, installation units, and operator case studies, Chemotherapy-Induced Myelosuppression Treatment opportunities, future road map, value series, eco-system player profiles and strategies. The Chemotherapy-Induced Myelosuppression Treatment report introduces predictions for important decisions from 2019 to 2025.
The Chemotherapy-Induced Myelosuppression Treatment Market report provides key driving factors which can…
